24.06.2024 17:01:33

EQS-PVR: SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

EQS Voting Rights Announcement: SCHOTT Pharma AG & Co. KGaA
SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

24.06.2024 / 17:01 CET/CEST
Dissemination of a Voting Rights Announcement transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Notification of Major Holdings

1. Details of issuer
Name: SCHOTT Pharma AG & Co. KGaA
Street: Hattenbergstraße 10
Postal code: 55122
City: Mainz
Germany
Legal Entity Identifier (LEI): 529900TU48UE99NHEY88

2. Reason for notification
X Acquisition/disposal of shares with voting rights
X Acquisition/disposal of instruments
  Change of breakdown of voting rights
  Other reason:

3. Details of person subject to the notification obligation
Legal entity: SMALLCAP World Fund, Inc.
City of registered office, country: Lutherville Timonium, United States of America (USA)

4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
 

5. Date on which threshold was crossed or reached:
20 Jun 2024

6. Total positions
  % of voting rights attached to shares
(total of 7.a.)		 % of voting rights through instruments
(total of 7.b.1 + 7.b.2)		 Total of both in %
(7.a. + 7.b.)		 Total number of voting rights pursuant to Sec. 41 WpHG
New 3.01 % 0.29 % 3.31 % 150614616
Previous notification 2.96 % 0.34 % 3.30 % /

7. Details on total positions
a. Voting rights attached to shares (Sec. 33, 34 WpHG)
ISIN Absolute In %
  Direct
(Sec. 33 WpHG)		 Indirect
(Sec. 34 WpHG)		 Direct
(Sec. 33 WpHG)		 Indirect
(Sec. 34 WpHG)
DE000A3ENQ51 4539746 0 3.01 % 0 %
Total 4539746 3.01 %

b.1. Instruments according to Sec. 38 (1) no. 1 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in %
0 0 %
    Total 0 0.00 %

b.2. Instruments according to Sec. 38 (1) no. 2 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in %
Rights to recall lent shares of Common Stock Physical settlement 442088 0.29 %
      Total 442088 0.29 %

8. Information in relation to the person subject to the notification obligation
X Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.).
  Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Name % of voting rights (if at least 3% or more) % of voting rights through instruments (if at least 5% or more) Total of both (if at least 5% or more)

9. In case of proxy voting according to Sec. 34 para. 3 WpHG
(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)

Date of general meeting:
Holding total positions after general meeting (6.) after annual general meeting:
Proportion of voting rights Proportion of instruments Total of both
% % %

10. Other explanatory remarks:
 

Date
21 Jun 2024


24.06.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
Language: English
Company: SCHOTT Pharma AG & Co. KGaA
Hattenbergstraße 10
55122 Mainz
Germany

 
End of News EQS News Service

1931933  24.06.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1931933&application_name=news&site_id=finanzen_net~~~069d1026-6a45-454f-953c-2a2c4451f1d6
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!

Nachrichten zu SCHOTT Pharmamehr Nachrichten

Analysen zu SCHOTT Pharmamehr Analysen

25.02.25 SCHOTT Pharma Hold Jefferies & Company Inc.
24.02.25 SCHOTT Pharma Buy UBS AG
17.02.25 SCHOTT Pharma Hold Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
14.02.25 SCHOTT Pharma Buy Deutsche Bank AG
13.02.25 SCHOTT Pharma Hold Jefferies & Company Inc.
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Newssuche

GO

Aktien in diesem Artikel

SCHOTT Pharma 24,02 -3,77% SCHOTT Pharma

Letzte Top-Ranking Nachrichten

15:58 Aktieninvestments: Michael Burrys Portfolio-Anpassungen im vierten Quartal 2024
03.03.25 Commerzbank-Depot im vierten Quartal 2024: Diese US-Aktien sind im Portfolio - NVIDIA- und Amazon reduziert
02.03.25 KW 9: Das sind die Tops und Flops der DAX-Aktien
02.03.25 KW 9: So performten die ATX-Aktien in der vergangenen Woche
02.03.25 Bitcoin, Ether & Co. im Februar 2025: Monatsbilanz der Kryptowährungen

Börse aktuell - Live Ticker

Zoll-Schock: ATX deutlich im Minus -- DAX tiefrot -- Wall Street schwächer -- Asiens Börsen schließen uneins
Der heimische und deutsche Aktienmarkt bewegen sich am Dienstag deutlich in der Verlustzone. Die US-Börsen notieren derweil tiefer. Am Dienstag fanden die wichtigsten asiatischen Märkten keine gemeinsame Richtung.

Nachrichten

Aktien ATX  DAX  EuroStoxx 50  Dow Jones  NASDAQ 100  Nikkei 225  S&P 500 

Kontakt  - Impressum - Werbung

Sitemap  - Datenschutz  - Disclaimer  - AGB  - Privatsphäre-Einstellungen